TP53 and cancer: They found that tamoxifen promoted the upregulation of TP53-induced glycolysis and apoptosis regulator (TIGAR), P53 regulated gene that can inhibit glycolysis, autophagy, and apoptosis and reduces ROS generation, in CAF co-cultured MCF-7 cells enhancing the oxidative mitochondrial metabolism, which provided the survival benefit to cancer cells.